CN Patent

CN120037179A — 抗流感病毒药物制剂

Assigned to Hefei Cosource Pharmaceutical Co ltd · Expires 2025-05-27 · 1y expired

What this patent protects

本公开提供了药物制剂，其配制原料包含：活性成分，选自帕拉米韦、扎那米韦、拉尼米韦和其水合物或溶剂合物中的一种；羧酸阴离子供体，选自双羟萘酸和羟萘酸中的至少一种；和第一pH调节剂，其为碱性pH调节剂。

USPTO Abstract

本公开提供了药物制剂，其配制原料包含：活性成分，选自帕拉米韦、扎那米韦、拉尼米韦和其水合物或溶剂合物中的一种；羧酸阴离子供体，选自双羟萘酸和羟萘酸中的至少一种；和第一pH调节剂，其为碱性pH调节剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN120037179A
Jurisdiction
CN
Classification
—
Expires
2025-05-27
Drug substance claim
No
Drug product claim
No
Assignee
Hefei Cosource Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.